Media Inquiries
For general media inquiries, please contact media@hhs.gov.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
The Biden-Harris Administration continues to build on progress made tackling sickle cell disease (SCD), recently holding a virtual panel to discuss SCD treatment, policy milestones, and future goals. The panel, hosted in observance of National Minority Health Month, by the Office of the Assistant Secretary for Health of the U.S. Department of Health and Human Services (HHS), also highlighted SCD leaders who fostered advances in SCD treatment and delivery of care, their achievements, and new policy priorities and objectives.
During his opening remarks for the event, HHS Secretary Xavier Becerra highlighted the importance of the Department’s work to address SCD. “Across HHS, we are working to advance health care quality and outcomes for SCD patients of all ages, by funding research, sharing data, and helping community-based organizations provide services and support. Too many people with the disease currently can’t access quality treatment or afford groundbreaking cell and gene therapies, on top of the historical discrimination they’ve faced trying to access necessary health care.”
Secretary Becerra also discussed how the Biden-Harris Administration is taking action to improving health care outcomes and quality of life for all SCD patients and their families across their lifespans. Those actions include:
To view the full panel discussion, click here.
The following representatives participated in the panel:
Receive the latest updates from the Secretary, Blogs, and News Releases
For general media inquiries, please contact media@hhs.gov.